Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (EP3066108) 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL BETA-D- GLUCOPYRANOSIDE ACETATE

Office : European Patent Office
Application Number: 14802974 Application Date: 30.10.2014
Publication Number: 3066108 Publication Date: 14.09.2016
Publication Kind : B1
Designated States: AL, AT, BA, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Prior PCT appl.: Application Number:US2014063161 ; Publication Number: Click to see the data
IPC:
C07H 17/02
A61K 31/7056
A61P 3/10
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
02
Heterocyclic radicals containing only nitrogen as ring hetero atoms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7052
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
7056
containing five-membered rings with nitrogen as a ring hetero atom
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
CPC:
C07H 17/02
A61K 31/7056
C07D 221/20
C07D 231/14
C07D 309/06
C07B 2200/13
Applicants: LILLY CO ELI
Inventors: REUTZEL-EDENS SUSAN MARIE
Priority Data: 201361901488 08.11.2013 US
2014063161 30.10.2014 US
Title: (DE) 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL-BETA-D-GLUCOPYRANOSID ACETAT
(EN) 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL BETA-D- GLUCOPYRANOSIDE ACETATE
(FR) ACÉTATE DE 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDÉC-2-YL)BUT-1-ÉN-1-YL]-2-MÉTHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL-BÊTA-D-GLUCOPYRANOSIDE
Abstract:
(EN) The present invention provides a compound of Formula I or hydrate thereof, useful for the treatment of diabetes.
(FR) Cette invention concerne un composé de Formule I ou un hydrate de celui-ci, utile pour le traitement du diabète.
Also published as:
UAa201603973CA2925128DOP2016000067IL244899CN105705509US20160215011
KR1020160067157EA201690749AU2014347065ID2017/05727MYPI 2016701635PH1/2016/500851
VN48279MA39019BR112016008428JP6197113TH170175IN201627009884
TN2016000112ES2703944WO/2015/069541